Inflammatory Cardiomyopathy Baseline Cohort (SFB/TR19)

University Medicine Greifswald920 enrolled

Overview

cohort of cardiomyopathy patients (suspected or validated inflammatory cardiomyopathy) recruited at baseline by the SFB-TR19 project. Standardized protocols used for the assessment of medical history and examinations, laboratory biomarkers, and the collection of various biosamples for biobanking purposes.

Study Type

OBSERVATIONAL

Enrollment

920

Conditions

Cardiomyopathies Heart Failure

Interventions

ObservationOTHER

None, observation only

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * suspected inflammatory cardiomyopathy at baseline Exclusion Criteria: * none

Locations (1)

Department of Internal Medicine B, University Medicine Greifswald

Greifswald, Mecklenburg-Vorpommern, Germany

Outcomes

Primary Outcomes

Cardiovascular events

Hospitalization (HF based. all-cause), interventions (ICD, pacemaker), myocardial infarction

Time frame: 1-year follow-ups

Secondary Outcomes

LVEF

Left ventricular ejection fraction at time of follow-up

Time frame: 1-year follow-ups

VO2peak

Exercise capacity by CPET

Time frame: 1-year follow-ups

QOL

Quality of life by questionnaire (Minnesota Living with HF questionnaire)

Time frame: 1-year follow-ups

Mortality

Mortality (HF-related, CVD, all-cause)

Time frame: 1-year follow-ups

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.